Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.47 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | GAA | P10253 | 1/20 | 0.44 |
| ▸ | HPGD | P15428 | 1/20 | 0.44 |
| ▸ | PLA2G2A | P14555 | 1/20 | 0.44 |
| ▸ | PLA2G5 | P39877 | 1/20 | 0.44 |
| ▸ | FPR2 | P25090 | 1/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.43 |
| ▸ | MAPT | P10636 | 1/20 | 0.43 |
| ▸ | THRB | P10828 | 1/20 | 0.43 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.43 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.43 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.43 |
| ▸ | THPO | P40225 | 1/20 | 0.43 |
| ▸ | RECQL | P46063 | 1/20 | 0.43 |
| ▸ | BLM | P54132 | 1/20 | 0.43 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.42 |
| ▸ | CA2 | P00918 | 2/20 | 0.41 |
| ▸ | CA1 | P00915 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1203937 | 1.00 | SMN1; SMN2 (0.47) | SMN1; SMN2ALDH1A1LMNAGAAHPGD | |
| SCHEMBL132349 | 1.00 | SMN1; SMN2 (0.47) | SMN1; SMN2ALDH1A1LMNAGAAHPGD | |
| Ammonia Solution, Strong SCHEMBL10483782 | 0.97 | SMN1; SMN2 (0.46) | SMN1; SMN2ALDH1A1LMNAGAAHPGD | |
| Ammonia Solution, Strong SCHEMBL10483779 | 0.97 | SMN1; SMN2 (0.46) | SMN1; SMN2ALDH1A1LMNAGAAHPGD | |
| SCHEMBL7105559 | 0.97 | SMN1; SMN2 (0.46) | SMN1; SMN2ALDH1A1LMNAGAAHPGD | |
| SCHEMBL8058978 | 0.97 | SMN1; SMN2 (0.46) | SMN1; SMN2ALDH1A1LMNAGAAHPGD | |
| SCHEMBL7360600 | 0.91 | SMN1; SMN2 (0.42) | SMN1; SMN2ALDH1A1LMNAGAAHPGD | |
| SCHEMBL7766358 | 0.91 | SMN1; SMN2 (0.42) | SMN1; SMN2ALDH1A1LMNAGAAHPGD | |
| SCHEMBL22829567 | 0.87 | SMN1; SMN2 (0.40) | SMN1; SMN2ALDH1A1LMNAGAAHPGD | |
| SCHEMBL25594806 | 0.86 | SMN1; SMN2 (0.48) | SMN1; SMN2ALDH1A1KDM4EMAPTTHRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 435 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-121851107-B | Aromatic acid salt of apolipoprotein E mimic peptide, and preparation method and medical application thereof | 中国药科大学 | 2026-05-15 | — | — | CN | claimed |
| WO-2025123045-A1 | PREDICTIVE AND DIAGNOSTIC SCREENING METHODS FOR ENDOMETRIAL CANCER | ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA (US) | 2025-06-12 | — | — | WO | claimed |
| US-12076432-B2 | Method of repairing oxidatively treated hair | CONOPCO, INC. (US) | 2024-09-03 | — | — | US | claimed |
| EP-4376826-A1 | AMINO ACID COMPOSITIONS AND METHODS FOR USE IN THE TREATMENT OF POST-ACUTE SEQUELAE OF COVID-19 | Axcella (Assignment for the benefit of Creditors), LLC (US) | 2024-06-05 | — | — | EP | claimed |
| WO-2024030909-A1 | BIOMARKERS OF AMINO ACID COMPOSITION TREATMENT RESPONSE IN LONG COVID | AXCELLA HEALTH INC. (US) | 2024-02-08 | — | — | WO | claimed |
| WO-2024026307-A1 | BIOMARKER FOR LONG COVID AND FATIGUE | AXCELLA HEALTH INC. (US) | 2024-02-01 | — | — | WO | claimed |
| CN-117191927-A | Biomarker combination for esophageal squamous carcinoma diagnosis and screening method thereof | 上海交通大学 | 2023-12-08 | — | — | CN | claimed |
| CN-116785236-A | Stable aqueous solution of ester peptide medicine | 海南普利制药股份有限公司 | 2023-09-22 | — | — | CN | claimed |
| WO-2023173615-A1 | STABLE ESTER PEPTIDE DRUG AQUEOUS SOLUTION | 海南普利制药股份有限公司 | 2023-09-21 | — | — | WO | claimed |
| CN-116519812-A | Application of biomarker in preparation of gestational diabetes diagnostic reagent | 杭州凯莱谱精准医疗检测技术有限公司 | 2023-08-01 | — | — | CN | claimed |
| US-20050026995-A1 | Injectable composition of paclitaxel | CHOONGWAE PHARMA CORPORATION (KR) | 2005-02-03 | — | — | US | claimed |
| WO-2003022247-A1 | INJECTABLE COMPOSITION OF PACLITAXEL | CHOONGWAE PHARMA CORPORATION (KR) | 2003-03-20 | — | — | WO | claimed |
| US-6524593-B1 | Alleviate or improve various cosmetic conditions and dermatological disorders, skin, hair, nails | TRISTRATA, INC. | 2003-02-25 | — | — | US | claimed |
| EP-1143925-A1 | TOPICAL COMPOSITION COMPRISING N-ACETYLALDOSAMINES OR N-ACETYLAMINO ACIDS | Yu, Ruey J., Dr. (US) | 2001-10-17 | — | — | EP | claimed |
| US-6159485-A | COSMETICS; SKIN DISORDERS | YUGENIC LIMITED PARTNERSHIP (US) | 2000-12-12 | — | — | US | claimed |
| WO-2000040217-B1 | TOPICAL COMPOSITION COMPRISING N-ACETYLALDOSAMINES OR N-ACETYLAMINO ACIDS | YUGENIC LIMITED PARTNERSHIP (US) | 2000-10-05 | — | — | WO | claimed |
| WO-2000040217-A1 | TOPICAL COMPOSITION COMPRISING N-ACETYLALDOSAMINES OR N-ACETYLAMINO ACIDS | YUGENIC LIMITED PARTNERSHIP (US) | 2000-07-13 | — | — | WO | claimed |
| US-6030823-A | FOR INDUSTRIAL PRODUCTION OF D-AMINO ACIDS FROM N-ACETYL-D-AMINO ACIDS | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 2000-02-29 | — | — | US | claimed |
| US-5212069-A | Forming dipeptides from amides and glycine, cysteine or methionine | DEGUSSA AKTIENGESELLSCHAFT (DE) | 1993-05-18 | — | — | US | claimed |
| US-5134073-A | Culture product of zoogloea ramigera | DEGUSSA AKTIENGESELLSCHAFT (DE) | 1992-07-28 | — | — | US | claimed |